Becton, Dickinson and Company (BDX) Guidance & Earnings Results

On 2026-08-06 Becton, Dickinson and Company raised guidance: "FY26 adjusted diluted EPS raised to $12.62-$12.72 from $12.52-$12.72; revenue growth expected toward high end of low single-digit range…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BDXBecton, Dickinson and CompanyFollow BDX — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 54.2B
P/E TTM: 59.9
Dividend yield: 2.1%
52-week: —
Next earnings: 5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Raised	FY26 adjusted diluted EPS raised to $12.62-$12.72 from $12.52-$12.72; revenue growth expected toward high end of low single-digit range (FXN) · full year
7 May 26	Raised	Raised full-year adjusted diluted EPS guidance; reaffirmed revenue growth guidance · full year
9 Feb 26	Reaffirmed	Adjusted Diluted EPS $12.35-$12.65 · full year
15 Oct 25	Reaffirmed	FY2025 adjusted diluted EPS at or above midpoint of prior guidance · full year
7 Aug 25	Raised	FY2025 adjusted diluted EPS raised to $14.30-$14.45 from $14.06-$14.34 (midpoint +$0.18, +9.4% growth); organic revenue growth reaffirmed at 3.0%-3.5%; GAAP revenue ~$21.8-$21.9B; adjusted revenue growth (FXN) 7.8%-8.3% · full year

Becton, Dickinson and Company — questions

What guidance did Becton, Dickinson and Company give?: On 2026-08-06: "FY26 adjusted diluted EPS raised to $12.62-$12.72 from $12.52-$12.72; revenue growth expected toward high end of low single-digit range (FXN)"
When does Becton, Dickinson and Company report earnings?: Becton, Dickinson and Company's next earnings report is expected on 2026-11-05.

Every figure on this page comes from Becton, Dickinson and Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.